Ebola Hemorrhagic Fever (EHF) is a deadly disease caused by the Filoviruses family. As such considering the present scenario, there is no known cure for the disease. Though tests with animals as victims have been conducted nothing has seemed to be effective. The famous Hypoimmune serum that was found out few years ago failed to protect the animal infected by the disease.

Though there is no known cure, Intensive care and management of blood flow and pressure have been ways of treatment. In places where previously outbreaks have occurred personal protective measures viz. personal hygiene while taking care of an infected person, matters a lot. Researchers are still not able to find an effective vaccine though many are under constant evaluation and improvisation.

Containment is a very important aspect of treatment. Suspected victims are isolated from other people and are placed in quarantine till all of them are dead. However intensive care techniques are adopted even in such containment places.

Awareness about the disease and its transmission ought to known by the health care providers. If not known they have to be taught so that their fears about the fear of getting affected by the disease are driven out. The health care providers should be stressed with the fact of not having any physical contact. The infected persons must be put surveillance 24*7 and should be put to tests at regular intervals.

If an infected person is having bleeding problems then that particular patient should be supplied with transfusions of platelets or fresh blood. There was this case during 6th and 22nd June 1995 when 8 people were reported to be infected by EHF. They were transfused with blood from 5 convalescent patients. Once they donated blood it was found out that it contained only anti-bodies and no antigens. The transfused patients were put under clinical observations and the results were observed similar to general EHF victims. After two weeks only one patient died out of the eight which is actually 12.5% mortality rate. As per studies, this was relatively less compared to the outbreak in Kiwit, Congo.

Even while such transfusions of blood the health care providers should not have contact with the blood or any other body fluid which is excreted. If they get into any means of physical contact then they will also get affected by EHF and will start showing symptoms of the same.

Vaccines and medicines are still yet on the impending side. Currently scientists are working on many potential vaccines but none have proven to be effective. Subsequent tests are being conducted on the same but the time factor is on a high roll. Drug therapy has always been an effective solution to all epidemics. Similarly, a new drug therapy has shown fundamental results of promise and is presently being evaluated under different experiments. But, as we said earlier the time factor is still being a concern.

By taking all the necessary precautions and conscientiously following a protocol of steps in intensive care the disease can be monitored in a way of not getting spread. Thus we can reduce the mortality rate and the outbreaks.